AIDS Therapies (Outcomes Research)
"CHORUS: A Novel HIV/AIDS Observational Cohort Study."
Published in AIDS Weekly, September 27th, 1999
According to an abstract submitted by the authors to the 28th Annual Meeting of the American College of Clinical Pharmacology, held September 16-18, 1999, in Rockville, Maryland, "In an era of increasing pressure to bring antiretrovirals to market faster and with an appreciation that the clinical experience of HIV patients may differ from the clinical trial, a comprehensive observational study to collect information on epidemiological, clinical, humanistic, and economic factors was initiated. The CHORUS (Collaborations in HIV Outcomes Research - U.S.) project is an on-going, real-time, community-based observational study of persons with HIV infection. Begun in August 1997, it utilizes an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1999-09-27)
More Articles from AIDS Weekly
- Prophylaxis
MAb Touted for Post-Exposure HIV Prevention - Conference Coverage (HIV Prevention)
PEP Compliance Low Among HIV Exposed HCWs - Conference Coverage (IHV)
Fertility Treatment May Protect Against HIV - Conference Coverage (IHV)
New Fusion Inhibitors Sought - AIDS Therapies
MRP4 Gene Involved in Nucleoside Resistance - Drug Development
2,6-Diaminopurine Z-Prodrug Has Antiviral Properties - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
